Canagliflozin for the Treatment of Diabetic Kidney Disease and Implications for Clinical Practice: A Narrative Review Davida Kruger Virginia Valentine 10.6084/m9.figshare.12164172.v1 https://adisjournals.figshare.com/articles/figure/Canagliflozin_for_the_Treatment_of_Diabetic_Kidney_Disease_and_Implications_for_Clinical_Practice_A_Narrative_Review/12164172 <p>The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC 2020.<b> </b></p> 2020-05-05 13:46:30 Canagliflozin Cardiovascular disease Diabetic kidney disease Randomized trials Sodium glucose co-transporter 2 inhibitor Type 2 diabetes